Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism

ESSENTIALS: There is no data on the use of idarucizumab in children with venous thromboembolism (VTE). We present the design of a trial that will assess the safety of idarucizumab in children with VTE. Patients will be recruited from two ongoing trials in children treated with dabigatran for VTE. Id...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Res Pract Thromb Haemost
Autors principals: Albisetti, Manuela, Schlosser, Arno, Brueckmann, Martina, Gropper, Savion, Glund, Stephan, Tartakovsky, Igor, Brandão, Leonardo R., Reilly, Paul A.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Articles: Thrombosis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5868044/
https://ncbi.nlm.nih.gov/pubmed/30046708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12053
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars